Literature DB >> 16246066

Atypical L-type channels are down-regulated in hypoxia.

L Callinan1, T V McCarthy, Y Maulet, J J Mackrill.   

Abstract

One type of cellular response to hypoxia is an increase in cytosolic Ca2+. VDCCs (voltage-dependent calcium channels) open upon membrane depolarization allowing inward current of Ca2+ ions. Two of the so-called L-type VDCC alpha1 subunits, Ca(v)1.2 and Ca(v)1.3, are found in the brain. We sought to investigate the effect of chronic hypoxia or treatment with a hypoxia-mimicking agent DFX (desferrioxamine mesylate) on expression of L-type VDCC in the SH-SY5Y neuroblastoma cell line. Western blotting identified two atypical forms of the L-type channel with apparent molecular masses of approx. 100 and 150 kDa, compared with typical forms of approx. 200 kDa. Immunofluorescence microscopy shows the approx. 100 kDa protein located within the cell and on the cell surface, while the approx. 150 kDa protein is intracellular with punctate staining. Further analysis revealed that this approx. 150 kDa protein co-localizes with nuclear proteins but not with markers for other intracellular compartments. In addition, these proteins are both down-regulated in DFX-treated and hypoxic cells, suggesting that the mechanism of down-regulation is along the HIF (hypoxia-inducible factor) pathway. This atypical localization of the 150 kDa protein suggests that it might play a role in nuclear calcium signalling in health and disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246066     DOI: 10.1042/BST20051137

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  1 in total

1.  Hypoxia reprograms calcium signaling and regulates myoglobin expression.

Authors:  Shane B Kanatous; Pradeep P A Mammen; Paul B Rosenberg; Cindy M Martin; Michael D White; J Michael Dimaio; Guojin Huang; Shmuel Muallem; Daniel J Garry
Journal:  Am J Physiol Cell Physiol       Date:  2008-11-12       Impact factor: 4.249

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.